Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants

• Published in: Neonatology (Basel, Switzerland) Vol. 109; no. 2; p. 139
• Main Authors: Bourgoin, Laura, Cipierre, Cecile, Hauet, Quentin, Basset, Helene, Gournay, Veronique, Rozé, Jean-Christophe, Flamant, Cyril, Gascoin, Geraldine
• Format: Journal Article
• Language: English
• Published: Switzerland 01.01.2016
• Subjects: Child, Preschool; Cohort Studies; Cyclooxygenase Inhibitors - adverse effects; Cyclooxygenase Inhibitors - therapeutic use; Ductus Arteriosus, Patent - complications; Ductus Arteriosus, Patent - drug therapy; Ductus Arteriosus, Patent - surgery; Ductus Arteriosus, Patent - therapy; Humans; Ibuprofen - adverse effects; Ibuprofen - therapeutic use; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases - drug therapy; Infant, Premature, Diseases - surgery; Infant, Premature, Diseases - therapy; Neurodevelopmental Disorders - etiology; Psychomotor Performance; Risk Factors; Treatment Outcome

Patent ductus arteriosus (PDA) is a condition frequently found in very preterm infants, and its treatment remains a subject of debate. Furthermore, there are only a few studies available that have examined the impact of these treatments on the neurological outcome of the patient. To evaluate the neu...